APIs
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
183
NCT06388772
Study to Assess PK, Safety and Tolerability Early in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 5, 2021
Completion: Jan 6, 2023
NCT06380699
Study to Assess PK, Safety and Tolerability in Healthy Subjects
Start: Mar 16, 2023
Completion: Dec 25, 2023
NCT06532058
Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia
Phase: Phase 2
Start: Aug 10, 2023
Completion: May 10, 2025
Loading map...